VIDEOS

ARTICLES

Register Now for the Targeted Therapies Patient Forum Join our faculty April 6, 2019, in Philadelphia, PA to learn about the newest breakthroughs in...

Register Now for the Targeted Therapies Patient Forum Join our faculty April 6, 2019, in Philadelphia, PA to learn about the newest breakthroughs in...

ONLINE COMMUNITY

I am in Tagrisso 40 mg with food at dinner and experiencing an annoying tickle and cough due to worsened gerd symptoms. I also take pantraprazole 2x...
I am in Tagrisso 40 mg with food at dinner and experiencing an annoying tickle and cough due to worsened gerd symptoms. I also take pantraprazole 2x...
Aaahh...sigh..... Once more we are where we were a couple of years ago. The CT scan came back with mixed results. The lung, head, and bones show no...
I have a 6 mm ground glass nodule. It was discovered incidentally. I had a 3 month follow up recently and my CT report says that it is likely a...
Hi, I hope someone from this great community can help. My mom was diagnosed with Stage 4 NSCLC 3.5 years ago. At the time of diagnosis she tested...

Recent Comments

Hi Beh and welcome to Grace…
Comment By JanineT GRACE … on Dec 8, 2022 11:34 am
Same EGFR G719A and S768I mutations in mom
Comment By JanineT GRACE … on Dec 8, 2022 11:34 am
Good to hear from you, Stan!
Comment By Amy B on Dec 7, 2022 9:19 am
Have you registered?
Comment By JanineT GRACE … on Dec 5, 2022 8:24 pm

Drs. Ross Camidge and Corey Langer: How Should We Manage Acquired Resistance with a Single Lesion or More Diffuse Progression?

Article

Drs. Ross Camidge and Corey Langer offer their insights on how to approach a patient with gradual progression in a single site, especially in the brain, or more multifocal progression after a good initial response to a targeted agent for lung cancer.

[powerpress]

Dr. William Pao on "How Concerned Should We Be About Different Testing Methods, as well as the Heterogeneity of Different Biopsy Results from the Same Patient?"

Article

Dr. William Pao explains the caveats of molecular testing in terms of differences in testing methods through different laboratories and the heterogeneity of molecular findings in different biopsies even within the same individual with lung cancer.

[powerpress]

Dr. Geoffrey Oxnard on Translating the Benefits of Molecular Oncology More Broadly: The Tissue is the Issue

Article

Dr. Geoffrey Oxnard conveys a central theme that the benefits of molecular oncology and optimal application of targeted therapies are dependent on a change in collecting tissue that works to obtain far more tissue than was historically required.

[powerpress]

Dr. Heather Wakelee: My Approach to Repeat Biopsies For Advanced NSCLC Patients Who Have Insufficient Tissue for Molecular Testing

Article

Dr. Heather Wakelee from Stanford University expresses her practice pattern for patients with advanced non-small cell lung cancer who would need a repeat biopsy to obtain sufficient tissue to perform molecular marker testing.

[powerpress]

Subscribe to Just Diagnosed